Top Income Companies To Watch For 2015: Stericycle Inc (SRCL)
Stericycle, Inc., incorporated on March 21, 1989, is in the business of managing regulated waste and providing an array of related and complementary services. The Company operates in the United States, Argentina, Brazil, Canada, Chile, Ireland, Japan, Mexico, Portugal, Romania, Spain, and the United Kingdom. The regulated waste services the Company provides include medical waste disposal, its Steri-Safe medical waste and compliance program, its Clinical Services program, its Bio Systems reusable sharps disposal management services, pharmaceutical waste disposal, and hazardous waste disposal. In addition to the Company's regulated waste services, the Company offers regulated recall and returns management services, patient communication services, and medical safety products. The Company's regulated recall and returns management services consist of a number of solutions for a variety of businesses but consist primarily of managing the recall, withdrawal or return of expired o r recalled products and pharmaceuticals. During the year ended December 31, 2012, it completed 41 acquisitions, of which 17 were domestic businesses and 24 were international businesses in Latin America, Europe, and Japan. In August 2013, Stericycle Inc acquired Eclipse Marketing.
The Company also provides communication services to healthcare providers to improve office productivity and communications with patients. As of December 31, 2012, the Company's worldwide networks included a total of 153 processing facilities, 141 transfer sites, and 64 recall and returns or communication services facilities. The Company serves approximately 541,000 customers worldwide, of which approximately 16,500 are large-quantity generators, such as hospitals, blood banks and pharmaceutical manufacturers, and approximately 524,500 are small-quantity generators, such as outpatient cl! inics, medical and dental offices, long-term and sub-acute care facilities, veterinary offices, muni cipalities and retail pharmacies. For large-quantity generat! ors of regulated waste such as hospitals and for pharmaceutical companies and distributors, the Company offers its regulated waste management services; its Bio Systems reusable sharps disposal management services; its pharmaceutical waste services; its Integrated Waste Stream Solutions (IWSS) program; a variety of products and services for infection control; its regulated recall and returns management services for expired or recalled products and pharmaceuticals, and variety of patient communication services. For small-quantity generators of regulated waste such as doctors' offices or retail pharmacies, the Company offers its Steri-Safe OSHA, HIPAA compliance, and clinical services programs.
The Company supplies specially designed reusable leak-resistant and puncture-resistant plastic containers to most of its large-quantity customers and many of its larger small-quantity customers. The Company collects containers or corrugated boxes of regulated waste from its customers depending upon customer requirements, contract terms and volume of waste generated. The waste is then transported directly to one of the Company's processing facilities or to one of its transfer stations where it is combined with other regulated waste and transported to a processing facility. The Company collects some expired or recalled products, but more typically, customer ships them directly to its processing facilities. Upon arrival at a processing facility, containers or boxes of regulated waste are typically scanned to verify that they do not contain any unacceptable substances like radioactive material. The regulated waste is then processed using one of the Company's various treatment or processing technologies. Upon completion of the particular process, the resulting waste or incinerator ash is transported for resource recovery, recycling or disposal ! in a land! fill owned by an unaffiliated third party. The Company provides complete documentation to its cust omers for all regulated waste that the Company collect in ac! cordance ! with applicable regulations and customer requirements.
Advisors' Opinion:- [By WWW.GURUFOCUS.COM]
Stericycle (SRCL) alone operates globally and generates close to $2 billion in annual revenues. Despite Stericycle's strong business performance during the recently reported quarter, the stock detracted from performance, partially driven by headlines of rumored regulatory action related to one of the Company's incinerators. We believe the issue is not meaningful to results and we would be willing to add to shares on pullbacks related to this. Stericycle's stock trades in the mid to high-‐teens EBITDA range, but the company routinely purchases smaller competitors for just 3X-‐6X EBITDA. This accretion is a byproduct of Stericycle's competitive positioning and we believe it paves a multi-‐year runway for double-‐digit growth.From David Rolfe (Trades, Portfolio)'s Wedgewood Partners first quarter 2014 commentary.
Also check out: David Rolfe Undervalued Stocks David Rolfe Top Growth Companies David Rolfe High Yield stocks, and Stocks that David Rolfe keeps buying
Currently 0.00/512345Rating: 0.0/5 (0 votes)
- [By Holly LaFon]
Stericycle (SRCL) alone operates globally and generates close to $2 billion in annual revenues. Despite Stericycle's strong business performance during the recently reported quarter, the stock detracted from performance, partially driven by headlines of rumored regulatory action related to one of the Company's incinerators. We believe the issue is not meaningful to results and we would be willing to add to shares on pullbacks related to this. Stericycle's stock trades in the mid to high-‐teens EBITDA range, but the company routinely purchases smaller competitors for just 3X-‐6X EBITDA. This accretion is a byproduct of Steri! cycle's c! ompetitive positioning and we believe it paves a multi-‐year runway for double-‐digit growth.
- [By Jonas Elmerraji]
We're seeing the exact same setup in shares of Stericycle (SRCL), but with one big difference: This stock hasn't broken out yet. Stericycle is another ascending triangle pattern, in this case with a resistance level at $120. A breakout above that $120 price ceiling is the signal that it's time to take this trade.
Whenever you're looking at any technical price pattern, it's critical to think in terms of buyers and sellers. Triangles and other pattern names are a good quick way to explain what's going on in a stock, but they're not the reason it's tradable – instead, it all comes down to supply and demand for shares.
That $120 resistance level is a price where there has been an excess of supply of shares; in other words, it's a place where sellers have been more eager to step in and take gains than buyers have been to buy. That's what makes a breakout above it so significant -- the move means that buyers are finally strong enough to absorb all of the excess supply above that price level.
Don't be early on the SRCL trade.
- [By Jonas Elmerraji]
First up is $10 billion medial waste disposal company Stericycle (SRCL). While SRCL has more or less only kept pace with the broad market in 2013, shares are at the point where they're looking primed to pop into December trading. Here's why.
Stericycle is currently forming an ascending triangle setup, a bullish price pattern that's formed by a horizontal resistance level above shares at $120 and uptrending support to the downside. Basically, as SRCL bounces in between those two technically-important price levels, it's getting squeezed closer and closer to a breakout above the $120 level. When that breakout happens, we've got a buy signal.
Whenever you're looking at any technical price pattern, it's critical to think in terms of those buyers and sellers. T! riangles ! and other pattern names are a good quick way to explain what's going on in a stock, but they're not the reason it's tradable – instead, it all comes down to supply and demand for shares.
That $57 resistance level is a price where there has been an excess of supply of shares; in other words, it's a place where sellers have been more eager to step in and take gains than buyers have been to buy. That's what makes a breakout above it so significant -- the move means that buyers are finally strong enough to absorb all of the excess supply above that price level.
Since HSBC is a longer-term pattern, the 200-day moving average is the spot to keep a stop loss after buying. It's been a pretty good proxy for support on the way up.
source from Top Stocks For 2015:http://www.topstocksblog.com/top-income-companies-to-watch-for-2015-4.html
No comments:
Post a Comment